Rare Diseases and Orphan Drugs

Drug discovery for rare diseases presents unique challenges due to the limited understanding of disease mechanisms, small patient populations, and often insufficient financial incentives for pharmaceutical companies. However, advancements in biomedical research, technological innovation, and regulatory incentives have led to increased efforts to develop treatments for rare diseases.

Submit Abstract

Related Tags:

1. Orphan Drugs International Conferences
2. Rare Diseases Meetings
3. Orphan Drugs Meetings
4. Rare Infection Conferences 2025